NYSE - Delayed Quote • USD
At close: 4:00 PM EDT
After hours: 7:53 PM EDT
Line
Candle
Baseline
Mountain
Bar
Loading Chart for CVS
9/21 12:03 PM
DELL
Date | |
Close | |
Open | |
High | |
Low | |
Volume |
- Previous Close
61.78 - Open
61.53 - Bid 60.00 x 800
- Ask 60.36 x 1000
- Day's Range
59.90 - 61.53 - 52 Week Range
52.77 - 83.25 - Volume
10,622,099 - Avg. Volume
12,268,942 - Market Cap (intraday)
75.674B - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
10.58 - EPS (TTM)
5.70 - Earnings Date Jul 31, 2024 - Aug 5, 2024
- Forward Dividend & Yield 2.66 (4.31%)
- Ex-Dividend Date Apr 19, 2024
- 1y Target Est
67.02
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
219,000
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Healthcare Plans
Industry
More about CVS Health Corporation
Recent News: CVS
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview: CVS
Trailing total returns as of 6/10/2024, which may include dividends or other distributions. Benchmark is
YTD Return
CVS
22.22%
S&P 500
12.39%
1-Year Return
CVS
12.97%
S&P 500
24.70%
3-Year Return
CVS
22.78%
S&P 500
27.05%
5-Year Return
CVS
29.31%
S&P 500
86.57%
Compare To: CVS
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
60.28
-2.43%
Mkt Cap 75.674B
Industry Healthcare Plans
495.00
+0.88%
Mkt Cap 455.591B
Industry Healthcare Plans
349.34
-0.70%
Mkt Cap 42.096B
Industry Healthcare Plans
338.65
+0.16%
Mkt Cap 96.202B
Industry Healthcare Plans
536.25
-0.20%
Mkt Cap 124.634B
Industry Healthcare Plans
69.84
+0.04%
Mkt Cap 37.271B
Industry Healthcare Plans
0.9855
-10.41%
Mkt Cap 489.239M
Industry Healthcare Plans
20.51
+6.16%
Mkt Cap 4.865B
Industry Healthcare Plans
307.98
-0.51%
Mkt Cap 18.043B
Industry Healthcare Plans
8.37
+0.36%
Mkt Cap 1.6B
Industry Healthcare Plans
5.58
+0.54%
Mkt Cap 45.893M
Industry Healthcare Plans
Statistics: CVS
Valuation Measures
As of 6/7/2024
Market Cap
77.56B
Enterprise Value
146.26B
Trailing P/E
10.84
Forward P/E
8.79
PEG Ratio (5yr expected)
1.60
Price/Sales (ttm)
0.22
Price/Book (mrq)
1.05
Enterprise Value/Revenue
0.41
Enterprise Value/EBITDA
8.52
Financial Highlights
Profitability and Income Statement
Profit Margin
2.04%
Return on Assets (ttm)
3.18%
Return on Equity (ttm)
10.09%
Revenue (ttm)
359.66B
Net Income Avi to Common (ttm)
7.32B
Diluted EPS (ttm)
5.70
Balance Sheet and Cash Flow
Total Cash (mrq)
13.09B
Total Debt/Equity (mrq)
110.31%
Levered Free Cash Flow (ttm)
8.36B
Research Analysis: CVS
Company Insights: CVS
Research Reports: CVS
People Also Watch
WBA Walgreens Boots Alliance, Inc.
15.94
+0.63%
ABBV AbbVie Inc.
170.46
+0.61%
UNH UnitedHealth Group Incorporated
495.00
+0.88%
BMY Bristol-Myers Squibb Company
42.57
+2.63%
TGT Target Corporation
148.52
+1.73%
JNJ Johnson & Johnson
147.13
+0.03%
ABT Abbott Laboratories
107.49
-0.08%
GILD Gilead Sciences, Inc.
65.25
+0.85%
LOW Lowe's Companies, Inc.
218.10
+0.66%
COST Costco Wholesale Corporation
848.34
+0.33%
FDX FedEx Corporation
253.72
+2.42%
UPS United Parcel Service, Inc.
137.68
+0.03%
PEP PepsiCo, Inc.
165.90
-3.01%
MMM 3M Company
100.66
-0.20%
CVX Chevron Corporation
156.74
+0.42%
MDT Medtronic plc
83.14
-1.11%